文献速递胃肠外科围术期管理与 ERAS

荧光引导腹腔镜结直肠手术术前结肠镜ICG注射的最佳剂量

Optimal ICG dosage of preoperative colonoscopic tattooing for fluorescence-guided laparoscopic colorectal surgery.
PubMed 文献 · Surg Endosc · 2021-02-26

本研究纳入192例结直肠癌患者,术前12-18小时行结肠镜黏膜下ICG注射,逐步降低ICG浓度以确定最佳方案。结果显示ICG剂量0.5-1 mg时荧光淋巴结映射、肿瘤定位和血管造影成功率最高,多点和非肥胖是独立成功因素,成功组淋巴结获取数更高。

要点

  • 术前结肠镜黏膜下ICG注射剂量0.5-1 mg为多功能应用的最佳范围。
  • 成功荧光淋巴结映射与低体重指数、多点注射及光源相关。
  • 成功组获取淋巴结总数显著高于失败组,转移淋巴结数无差异。

核心结论

  • 术前结肠镜黏膜下注射ICG剂量0.5-1 mg是荧光引导腹腔镜结直肠手术多功能应用的最佳方案。

研究设计与样本

  • 前瞻性研究纳入192例结直肠癌患者,于2017年5月至2019年12月行术前12-18小时结肠镜黏膜下ICG注射。
  • ICG注射方案基于总剂量和注射点数调整,浓度从标准2.5 mg/ml逐步降至最低0.2 mg/ml。

主要发现

  • ICG剂量0.5-1 mg时荧光淋巴结映射、肿瘤定位和ICG血管造影成功率最高。
  • 成功荧光淋巴结映射与ICG剂量0.5-1 mg、多点黏膜下注射、癌症位置、相机光源和较低BMI相关。
  • 多因素分析中相机光源、非肥胖和多点注射是成功荧光淋巴结映射的独立因素。
  • 成功组平均获取淋巴结总数显著高于失败组(p < 0.001),转移淋巴结数两组相当(p = 0.859)。

临床怎么用

  • 术前12-18小时行结肠镜黏膜下ICG注射,剂量选择0.5-1 mg以实现荧光淋巴结映射、肿瘤定位和血管造影。
  • 优先采用多点黏膜下注射,并注意相机光源选择,尤其对非肥胖患者可提高成功率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Indocyanine green (ICG) is a multifunctional dye used in tumor localization, tissue perfusion, and lymph node (LN) mapping during fluorescence-guided laparoscopic colorectal surgery. PURPOSE: This study aimed to establish the optimal protocol for preoperative endoscopic submucosal ICG injection to perform fluorescence lymph node mapping (FLNM), along with undisturbed fluorescent tumor localization and ICG angiography during a single surgery. METHODS: Colorectal cancer patients (n = 192) were enrolled from May 2017 to December 2019. Colonoscopic submucosal ICG injection was performed 12 to 18 h before surgery. ICG injection protocols were modified based on the total injected ICG (mg) and tattooing site number. The concentrations of ICG were gradually decreased from the standard dose (2.5 mg/ml) to the minimum dose (0.2 mg/ml). Successful FLNM (FLNM-s) was defined as distinct fluorescent LNs observed under NIR camera. The patient's age, sex, body mass index (BMI), stage, cancer location, obstruction, and laboratory findings were compared between the FLNM-s and failed FLNM (FLNM-f) groups to identify clinical and pathological factors that affect FLNM. RESULTS: In the ICG dose section of 0.5 to 1 mg, the success rate was highest within all functions including FLNM, fluorescent tumor localization, and ICG angiography. FLNM-s was related to ICG dose (0.5-1 mg), multiple submucosal injections, location of cancer, camera light source, and lower BMI. In the multivariate analysis, camera light source, non-obesity, and multiple injections were independent factors for FLNM-s). The mean total number of harvested LNs was significantly higher in the FLNM-s group than that in the FLNM-f group (p < 0.001). The number of metastatic lymph nodes was comparable between the two groups (p = 0.859). CONCLUSIONS: Preoperative, endoscopic submucosal ICG injection with dose range 0.5 to 1 mg would be optimal protocol for multifunctional ICG applications during fluorescence-guided laparoscopic colorectal surgery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Ahn HM, Son GM, Lee IY, et al. Optimal ICG dosage of preoperative colonoscopic tattooing for fluorescence-guided laparoscopic colorectal surgery. Surg Endosc. 2021. PMID: 33638107. doi:10.1007/s00464-021-08382-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。